The effect of urapidil on neurogenic bladder: A placebo controlled double-blind study

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1125-1130

  Yasuda, Kosaku ^a   Yamanishi, Tomonori ^a   Kawabe, Kazuki ^a   Ohshima, Hiroyuki ^a   Morita, Takashi ^a  

^a NONE

Author keywords

adrenergic alpha receptor blockaders; bladder, neurogenic; urodynamics

Indexed keywords

URAPIDIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICTURITION; NEUROGENIC BLADDER; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URETHRA PRESSURE; URINE INCONTINENCE; URODYNAMICS;

EID: 0029776050     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65723-9     Document Type: Article

References (22)

1. Raz, S., Zeigler, M. and Caine, M.: Pharmacological receptors in the prostate. Brit. J. Urol., 45: 663, 1973.
2. Sundin, T., Dahlström, A., Norlén, L. and Svedmyr, N.: The sympathetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation. Invest. Urol., 14: 322, 1977.
3. Edvardsen, P. and Setekleiv, J.: Distribution of adrenergic receptors in the urinary bladder of cats, rabbits and guinea-pigs. Acta Pharmacol., 26: 437, 1968.
4. Caine, M.: The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J. Urol., 136: 1, 1986.
5. Kirby, R. S., Coppinger, S. W. C., Corcoran, M. O., Chapple, C. R., Flannigan, M. and Milroy, E. J. G.: Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. Brit. J. Urol., 60: 136, 1987.
6. Krane, R. J. and Olsson, C. A.: Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations. J. Urol., 110: 653, 1973.
7. O'Riordan, J. I., Doherty, C., Javed, M., Brophy, D., Hutchinson, M. and Quinlan, D.: Do α-blockers have a role in lower urinary tract dysfunction in multiple sclerosis? J. Urol., 153: 1114, 1995.
8. Koyanagi, T., Togashi, M., Maru, A., Orikasa, S., Soma, F., Shimazaki, J., Yasuda, K., Aso, Y., Honma, Y., Miyake, K., Kondo, A., Kumazawa, J. and Takei, M.: Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder - a double-blind study. Acta Urol. Jap., 36: 1233, 1990.
9. Whitfield, H. N., Doyle, P. T., Mayo, M. E. and Poopalsingham, N.: The effect of adrenergic blocking drugs on outflow resistance. Brit. J. Urol., 47: 823, 1976.
10. Donker, P. J., Ivanovici, F. and Noach, E. L.: Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Brit. J. Urol., 44: 180, 1972.
11. Kaneko, Y.: Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension. Drugs, suppl. 6, 35: 156, 1988.
12. Kawabe, K., Tsuchida, S., Shimazaki, J., Morita, T., Yasuda, K. and Kageyama, S.: Effect of urapidil on benign prostatic hypertrophy: a multicenter, double-blind study. Urol. Int., 50: 27, 1993.
13. Yamanishi, T., Yasuda, K., Tojo, M., Hattori, T., Sakakibara, R. and Shimazaki, J.: Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction. Paraplegia, 32: 271, 1994.
14. Abrams, P., Blaivas, J. G., Stanton, S. L. and Andersen, J. T.: The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand. J. Urol. Nephrol., suppl., 114: 5, 1988.
15. Blaivas, J. G., Sinha, H. P., Zayed, A. A. H. and Labib, K. B.: Detrusor-external sphincter dyssynergia: a detailed electromyographic study. J. Urol., 125: 545, 1981.
16. Susset, J. G., Rabinovitch, H. H., Rosario, F. and Mackinnon, K. J.: Measurement of urethral resistance. J. Urol., 96: 746, 1966.
17. Lenaghan, D.: The diagnosis of prostatic obstruction by measurement of urethral resistance to flow. J. Urol., 103: 320, 1970.
18. Jensen, D., Jr.: Uninhibited neurogenic bladder treated with prazosin. Scand. J. Urol. Nephrol., 15: 229, 1981.
19. Yamanishi, T., Yasuda, K., Murayama, N., Nagashima, K., Tojo, M., Wada, T. and Shimazaki, J.: Clinical effects of moxisylyte hydrochloride on micturition disturbance due to neurogenic bladder. Nishinihon J. Urol., 53: 283, 1991.
20. Cramer, P., Neveux, E., Régnier, F., Depassio, J. and Bérard, E.: Bladder-neck opening test in spinal cord injury patients using a new i.v. alpha-blocking agent, alfuzosin. Paraplegia, 27:119, 1989.
21. Andersson, K. E., Ek, A., Hedlund, H. and Mattiasson, A.: Effect of prazosin on isolated human urethra and in patients with lower motor neurons lesions. Invest. Urol., 19: 39, 1981.
22. Nørdling, J.: Relationship of the sympathetic nervous system to lower motor neurone lesions and the bladder. Clin. Sci., suppl., 14: 51S, 1986.